【中航证券】科伦药业（002422）-2024年报和2025年一季报点评：创新管线逐步兑现，国际化推动长期增长-250528（4页）.pdf

1、 1 报表预测报表预测单位:百万元单位:百万元会计年度会计年度2022202220232023202420242025E2025E2026E2026E2027E2027E利润表利润表 营业收入18,912.6521,453.9321,812.4122,505.6624,309.7626,360.85 减:营业成本8,959.2010,205.5310,536.8210,714.1311,552.9212,489.66 税金及附加251.02302.73276.22300.43324.51351.89 主营业务利润 主营业务利润9,702.4310,945.6710,999.3711,491.1

2、012,432.3313,519.29 减:销售费用4,685.954,449.723,492.623,938.494,254.214,613.15 管理费用924.581,142.051,308.491,350.341,458.591,581.65 研发费用1,795.091,943.572,170.542,228.062,382.362,583.36 财务费用478.18233.7666.18140.6078.54-31.69 经营性利润 经营性利润1,818.633,176.573,961.543,833.614,258.644,772.82 加:资产减值损失-44.03-130.55-

3、130.59-134.74-145.54-157.82 信用减值损失-62.45-45.98-109.13-78.38-84.67-91.81 其他经营损益0.000.000.000.000.000.00 投资收益234.43358.88345.02312.78312.78312.78 公允价值变动损益9.8614.6719.900.000.000.00 资产处置收益5.402.630.812.942.942.94 其他收益237.02277.94338.78284.58284.58284.58 营业利润 营业利润2,198.863,654.144,426.324,220.794,628.73

4、5,123.49 加:其他非经营损益0.000.000.000.000.000.00 营业外收入7.0311.868.819.239.239.23 减:营业外支出134.4285.57149.77123.26123.26123.26 利润总额 利润总额2,071.463,580.434,285.364,106.764,514.705,009.46 减:所得税364.00933.79923.40892.54981.201,088.73 净利润 净利润1,707.462,646.643,361.953,214.223,533.503,920.73 减:少数股东损益-1.24 190.53426.0

5、6212.13233.20258.76 归属母公司股东净利润 归属母公司股东净利润1,708.702,456.112,935.893,002.093,300.303,661.97资产负债表资产负债表 货币资金4,725.304,675.483,973.919,002.279,723.9111,823.31 交易性金融资产448.111,691.091,921.161,921.161,921.161,921.16 应收票据0.000.000.000.000.000.00 应收账款7,183.746,120.166,098.117,086.877,654.978,300.84 预付账款429.14

6、386.36383.49437.21472.26512.11 其他应收款254.27162.49126.17201.07217.19235.51 存货3,190.703,839.803,800.623,903.814,209.434,550.74 其他流动资产369.731,414.661,632.521,202.791,299.211,408.83 长期股权投资3,792.443,976.374,209.814,510.024,810.225,110.43 金融资产投资15.0115.7770.7470.7470.7470.74 投资性房地产0.000.000.000.000.000.00